vixarelimab (RG6536) - Roche
Cibinqo (abrocitinib) - Pfizer
povorcitinib (INCB54707) - Incyte
barzolvolimab (CDX-0159) - Celldex
Mitchga (nemolizumab) - Galderma
Dupixent (dupilumab) - Sanofi, Regeneron
http://www.ncbi.nlm.nih.gov/pubmed/38722190
 
Claudia Zeidler; Julia Thünemann; Kerstin Steinbrink; Sonja Ständer; Svenja Müller
 
May 9, 2024
 
Next